%% Created using Papers on Thu, 26 Mar 2015.
%% http://papersapp.com/papers/

@article{vanderMaaten:2008tm,
author = {van der Maaten, L and Hinton, G},
title = {{Visualizing Data using t-SNE}},
journal = {jmlr.csail.mit.edu},
year = {2008},
volume = {9},
month = nov,
read = {Yes},
rating = {0},
date-added = {2014-11-06T13:45:26GMT},
date-modified = {2014-11-21T16:28:45GMT},
abstract = {We present a new technique called {\textquotedblleft}t-SNE{\textquotedblright} that visualizes high-dimensional data by giving each datapoint a location in a two or three-dimensional map. The technique is a variation of Stochastic Neighbor Embedding (Hinton and Roweis, 2002) that is much easier to optimize, and produces significantly better visualizations by reducing the tendency to crowd points together in the center of the map. t-SNE is better than existing techniques at creating a single map that reveals structure at many different scales. This is particularly important for high-dimensional data that lie on several different, but related, low-dimensional manifolds, such as images of objects from multiple classes seen from multiple viewpoints. For visualizing the structure of very large data sets, we show how t-SNE can use random walks on neighborhood graphs to allow the implicit structure of all of the data to influence the way in which a subset of the data is displayed. We illustrate the performance of t-SNE on a wide variety of data sets and compare it with many other non-parametric visualization techniques, including Sammon mapping, Isomap, and Locally Linear Embedding. The visualiza- tions produced by t-SNE are significantly better than those produced by the other techniques on almost all of the data sets.},
url = {http://jmlr.csail.mit.edu/papers/volume9/vandermaaten08a/vandermaaten08a.pdf},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/0C/0CD77D3A-26C4-4137-A897-2B6BA6AE5EDD.pdf},
file = {{0CD77D3A-26C4-4137-A897-2B6BA6AE5EDD.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/0C/0CD77D3A-26C4-4137-A897-2B6BA6AE5EDD.pdf:application/pdf}},
uri = {\url{papers3://publication/uuid/434DDC3A-62C2-466B-994C-3365952AFF11}}
}

@article{Fruchterman:1991ko,
author = {Fruchterman, Thomas M J and Reingold, Edward M},
title = {{Graph drawing by force-directed placement}},
journal = {Software: Practice and Experience},
year = {1991},
volume = {21},
number = {11},
pages = {1129--1164},
month = nov,
publisher = {John Wiley {\&} Sons, Ltd.},
doi = {10.1002/spe.4380211102},
language = {English},
read = {Yes},
rating = {0},
date-added = {2014-12-05T17:21:40GMT},
date-modified = {2014-12-05T17:22:03GMT},
url = {http://doi.wiley.com/10.1002/spe.4380211102},
uri = {\url{papers3://publication/doi/10.1002/spe.4380211102}}
}

@article{Stockwell:2008bm,
author = {Stockwell, Brent R and Giaever, Guri and Nislow, Corey and Leh{\'a}r, Joseph},
title = {{Combination chemical genetics}},
journal = {Nature Chemical Biology},
year = {2008},
volume = {4},
number = {11},
pages = {674--681},
month = nov,
keywords = {recommended by Andreas},
doi = {10.1038/nchembio.120},
pmid = {18936752},
pmcid = {PMC2712875},
read = {Yes},
rating = {0},
date-added = {2013-11-11T23:36:47GMT},
date-modified = {2014-11-25T17:37:17GMT},
abstract = {Predicting the behavior of living organisms is an enormous challenge given their vast complexity. Efforts to model biological systems require large datasets generated by physical binding experiments and perturbation studies. Genetic perturbations have proven important and are greatly facilitated by the advent of comprehensive mutant libraries in model organisms. Small- molecule chemical perturbagens provide a complementary approach, especially for systems that lack mutant libraries, and can easily probe the function of essential genes. Though single chemical or genetic perturbations provide crucial information associating individual components (for example, genes, proteins or small molecules) with pathways or phenotypes, functional relationships between pathways and modules of components are most effectively obtained from combined perturbation experiments. Here we review the current state of and discuss some future directions for {\textquoteleft}combination chemical genetics{\textquoteright}, the systematic application of multiple chemical or mixed chemical and genetic perturbations, both to gain insight into biological systems and to facilitate medical discoveries.},
url = {http://www.nature.com/doifinder/10.1038/nchembio.120},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/5D/5D5C0A78-640F-4AE3-A9B2-6639E2F07231/5D5C0A78-640F-4AE3-A9B2-6639E2F07231.pdf},
file = {{5D5C0A78-640F-4AE3-A9B2-6639E2F07231.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/5D/5D5C0A78-640F-4AE3-A9B2-6639E2F07231/5D5C0A78-640F-4AE3-A9B2-6639E2F07231.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1038/nchembio.120}}
}

@article{Yuan:2012bn,
author = {Yuan, Shuqiang and Wang, Feng and Wang, Jianping and Huang, Peng and Chen, Gang and Zhang, Hui and Feng, Li and Wang, Lei and Colman, Howard and Keating, Michael J and Li, Xiaonan and Xu, Rui-Hua},
title = {{Effective Elimination of Cancer Stem Cells By a Novel Drug Combination Strategy}},
journal = {STEM CELLS},
year = {2012},
volume = {31},
number = {1},
pages = {23--34},
month = dec,
keywords = {recommended by Andreas},
doi = {10.1002/stem.1273},
language = {English},
read = {Yes},
rating = {0},
date-added = {2013-11-11T23:40:24GMT},
date-modified = {2015-03-08T17:36:13GMT},
url = {http://doi.wiley.com/10.1002/stem.1273},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/1E/1E590C94-17DD-4409-B81E-F4303DEA6524/1E590C94-17DD-4409-B81E-F4303DEA6524.pdf},
file = {{1E590C94-17DD-4409-B81E-F4303DEA6524.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/1E/1E590C94-17DD-4409-B81E-F4303DEA6524/1E590C94-17DD-4409-B81E-F4303DEA6524.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1002/stem.1273}}
}

@article{Pearson:1901gs,
author = {Pearson, Karl},
title = {{On lines and planes of closest fit to systems of points in space}},
journal = {Philosophical Magazine Series 6},
year = {1901},
volume = {2},
number = {11},
pages = {559--572},
month = nov,
doi = {10.1080/14786440109462720},
language = {English},
rating = {0},
date-added = {2014-11-25T18:07:11GMT},
date-modified = {2014-11-25T21:07:53GMT},
url = {http://www.tandfonline.com/doi/abs/10.1080/14786440109462720},
uri = {\url{papers3://publication/doi/10.1080/14786440109462720}}
}

@article{Katouli:2010gt,
author = {Katouli, Allen a and Komarova, Natalia L},
title = {{Optimizing Combination Therapies with Existing and Future CML Drugs}},
journal = {PLoS ONE},
year = {2010},
volume = {5},
number = {8},
pages = {e12300},
month = aug,
keywords = {recommended by Andreas},
doi = {10.1371/journal.pone.0012300},
language = {English},
read = {Yes},
rating = {0},
date-added = {2013-11-11T23:49:26GMT},
date-modified = {2015-03-08T17:40:52GMT},
url = {http://dx.plos.org/10.1371/journal.pone.0012300},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/A1/A1535DEB-6F73-48C3-999B-5518050F4068/A1535DEB-6F73-48C3-999B-5518050F4068.pdf},
file = {{A1535DEB-6F73-48C3-999B-5518050F4068.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/A1/A1535DEB-6F73-48C3-999B-5518050F4068/A1535DEB-6F73-48C3-999B-5518050F4068.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1371/journal.pone.0012300}}
}

@article{Jia:2009hja,
author = {Jia, Jia and Zhu, Feng and Ma, Xiaohua and Cao, Zhiwei and Cao, Zhiwei W and Li, Yixue and Li, Yixue X and Chen, Yu Zong},
title = {{Mechanisms of drug combinations: interaction and network perspectives.}},
journal = {Nature Reviews Drug Discovery},
year = {2009},
volume = {8},
number = {2},
pages = {111--128},
month = feb,
affiliation = {Bioinformatics and Drug Design Group, Department of Pharmacy, Department of Biological Science, Center for Computational Science and Engineering, National University of Singapore, Singapore 117543.},
doi = {10.1038/nrd2683},
pmid = {19180105},
language = {English},
read = {Yes},
rating = {0},
date-added = {2014-08-12T10:55:27GMT},
date-modified = {2014-11-25T17:36:35GMT},
abstract = {Understanding the molecular mechanisms underlying synergistic, potentiative and antagonistic effects of drug combinations could facilitate the discovery of novel efficacious combinations and multi-targeted agents. In this article, we describe an extensive investigation of the published literature on drug combinations for which the combination effect has been evaluated by rigorous analysis methods and for which relevant molecular interaction profiles of the drugs involved are available. Analysis of the 117 drug combinations identified reveals general and specific modes of action, and highlights the potential value of molecular interaction profiles in the discovery of novel multicomponent therapies.},
url = {http://www.nature.com/doifinder/10.1038/nrd2683},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/EB/EBD6932B-A704-4DD1-A68A-830DF6A44ABC.pdf},
file = {{EBD6932B-A704-4DD1-A68A-830DF6A44ABC.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/EB/EBD6932B-A704-4DD1-A68A-830DF6A44ABC.pdf:application/pdf;EBD6932B-A704-4DD1-A68A-830DF6A44ABC.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/EB/EBD6932B-A704-4DD1-A68A-830DF6A44ABC.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1038/nrd2683}}
}

@inproceedings{Holbeck:2012bd,
author = {Holbeck, S and Collins, J M and Doroshow, J H},
title = {{27 NCI-60 Combination Screening Matrix of Approved Anticancer Drugs}},
booktitle = {European Journal of Cancer},
year = {2012},
pages = {11},
month = nov,
keywords = {recommended by Andreas},
doi = {10.1016/S0959-8049(12)71826-9},
language = {English},
rating = {0},
date-added = {2013-11-11T23:35:17GMT},
date-modified = {2015-03-26T12:54:38GMT},
url = {http://linkinghub.elsevier.com/retrieve/pii/S0959804912718269},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/DD/DDE20575-5F27-43D5-82AC-62EF68D53462/DDE20575-5F27-43D5-82AC-62EF68D53462.pdf},
file = {{DDE20575-5F27-43D5-82AC-62EF68D53462.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/DD/DDE20575-5F27-43D5-82AC-62EF68D53462/DDE20575-5F27-43D5-82AC-62EF68D53462.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1016/S0959-8049(12)71826-9}}
}

@incollection{Baur:2005cq,
author = {Baur, Michael and Brandes, Ulrik},
title = {{Crossing Reduction in Circular Layouts}},
booktitle = {Graph-Theoretic Concepts in Computer Science},
year = {2005},
pages = {332--343},
publisher = {Springer Berlin Heidelberg},
address = {Berlin, Heidelberg},
month = jan,
doi = {10.1007/978-3-540-30559-0_28},
isbn = {978-3-540-24132-4},
language = {English},
read = {Yes},
rating = {0},
date-added = {2014-12-05T15:49:05GMT},
date-modified = {2014-12-05T15:51:15GMT},
url = {http://link.springer.com/10.1007/978-3-540-30559-0_28},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/1D/1D6B1530-CC81-4EF2-A13D-1EEF0BB4EBDE.pdf},
file = {{1D6B1530-CC81-4EF2-A13D-1EEF0BB4EBDE.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/1D/1D6B1530-CC81-4EF2-A13D-1EEF0BB4EBDE.pdf:application/pdf;1D6B1530-CC81-4EF2-A13D-1EEF0BB4EBDE.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/1D/1D6B1530-CC81-4EF2-A13D-1EEF0BB4EBDE.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1007/978-3-540-30559-0_28}}
}

@article{Wang:2012gla,
author = {Wang, Yin-Ying and Xu, Ke-Jia and Song, Jiangning and Zhao, Xing-Ming},
title = {{Exploring drug combinations in genetic interaction network}},
journal = {BMC Bioinformatics},
year = {2012},
volume = {13},
number = {Suppl 7},
pages = {S7},
month = may,
publisher = {BioMed Central Ltd},
keywords = {AndreasJan13},
doi = {10.1186/1471-2105-13-S7-S7},
pmid = {22595004},
pmcid = {PMC3348050},
read = {Yes},
rating = {0},
date-added = {2014-01-22T10:08:15GMT},
date-modified = {2015-03-26T12:22:03GMT},
abstract = {BMC Bioinformatics 2012, 13:S7. doi:10.1186/1471-2105-13-S7-S7},
url = {http://www.biomedcentral.com/1471-2105/13/S7/S7},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/31/31F2131C-0EB8-4B0E-8ED3-872F626D8EAB.pdf},
file = {{31F2131C-0EB8-4B0E-8ED3-872F626D8EAB.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/31/31F2131C-0EB8-4B0E-8ED3-872F626D8EAB.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1186/1471-2105-13-S7-S7}}
}

@article{Guimera:2013jh,
author = {Guimer{\`a}, Roger and Sales-Pardo, Marta},
title = {{A network inference method for large-scale unsupervised identification of novel drug-drug interactions.}},
journal = {PLoS Computational Biology},
year = {2013},
volume = {9},
number = {12},
pages = {e1003374},
month = dec,
publisher = {Public Library of Science},
affiliation = {Instituci{\'o} Catalana de Recerca i Estudis Avan{\c c}ats (ICREA), Barcelona, Catalonia, Spain ; Departament d'Enginyeria Qu{\'\i}mica, Universitat Rovira i Virgili, Tarragona, Catalonia, Spain.},
doi = {10.1371/journal.pcbi.1003374},
pmid = {24339767},
pmcid = {PMC3854677},
language = {English},
read = {Yes},
rating = {0},
date-added = {2014-08-12T10:53:35GMT},
date-modified = {2014-11-29T20:59:50GMT},
abstract = {Characterizing interactions between drugs is important to avoid potentially harmful combinations, to reduce off-target effects of treatments and to fight antibiotic resistant pathogens, among others. Here we present a network inference algorithm to predict uncharacterized drug-drug interactions. Our algorithm takes, as its only input, sets of previously reported interactions, and does not require any pharmacological or biochemical information about the drugs, their targets or their mechanisms of action. Because the models we use are abstract, our approach can deal with adverse interactions, synergistic/antagonistic/suppressing interactions, or any other type of drug interaction. We show that our method is able to accurately predict interactions, both in exhaustive pairwise interaction data between small sets of drugs, and in large-scale databases. We also demonstrate that our algorithm can be used efficiently to discover interactions of new drugs as part of the drug discovery process.},
url = {http://dx.plos.org/10.1371/journal.pcbi.1003374},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/3A/3AAF958B-ABA7-4153-9E18-22A592D5D408.pdf},
file = {{3AAF958B-ABA7-4153-9E18-22A592D5D408.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/3A/3AAF958B-ABA7-4153-9E18-22A592D5D408.pdf:application/pdf;3AAF958B-ABA7-4153-9E18-22A592D5D408.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/3A/3AAF958B-ABA7-4153-9E18-22A592D5D408.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1371/journal.pcbi.1003374}}
}

@article{Yeh:2006bb,
author = {Yeh, Pamela and Tschumi, Ariane I and Kishony, Roy},
title = {{Functional classification of drugs by properties of their pairwise interactions}},
journal = {Nature Genetics},
year = {2006},
volume = {38},
number = {4},
pages = {489--494},
month = mar,
keywords = {recommended by Andreas},
doi = {10.1038/ng1755},
read = {Yes},
rating = {0},
date-added = {2013-11-11T23:41:07GMT},
date-modified = {2014-11-21T17:10:05GMT},
url = {http://www.nature.com/doifinder/10.1038/ng1755},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/7E/7ED7FFF7-BCC6-4015-AB30-47CAF21F8BFF/7ED7FFF7-BCC6-4015-AB30-47CAF21F8BFF.pdf},
file = {{7ED7FFF7-BCC6-4015-AB30-47CAF21F8BFF.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/7E/7ED7FFF7-BCC6-4015-AB30-47CAF21F8BFF/7ED7FFF7-BCC6-4015-AB30-47CAF21F8BFF.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1038/ng1755}}
}

@article{Morgan:1965di,
author = {Morgan, H L},
title = {{The Generation of a Unique Machine Description for Chemical Structures-A Technique Developed at Chemical Abstracts Service.}},
journal = {Journal of Chemical Documentation},
year = {1965},
volume = {5},
number = {2},
pages = {107--113},
month = may,
doi = {10.1021/c160017a018},
language = {English},
rating = {0},
date-added = {2014-11-06T13:30:30GMT},
date-modified = {2015-03-26T12:22:03GMT},
url = {http://pubs.acs.org/doi/abs/10.1021/c160017a018},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/0D/0D569B60-0521-4A69-81C8-93D96C1727C2.pdf},
file = {{0D569B60-0521-4A69-81C8-93D96C1727C2.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/0D/0D569B60-0521-4A69-81C8-93D96C1727C2.pdf:application/pdf;0D569B60-0521-4A69-81C8-93D96C1727C2.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/0D/0D569B60-0521-4A69-81C8-93D96C1727C2.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1021/c160017a018}}
}

@article{Lehar:2007wv,
author = {Leh{\'a}r, Joseph and Zimmermann, G R and Krueger, A S and Molnar, R A and Ledell, J T and Heilbut, A M and Short III, G F and Giusti, L C and Nolan, G P and Magid, O A and Lee, M S and Borisy, A A and Stockwell, B R and Keith, C T},
title = {{Chemical combination effects predict connectivity in biological systems}},
journal = {Molecular Systems Biology},
year = {2007},
volume = {3},
keywords = {recommended by Andreas},
read = {Yes},
rating = {0},
date-added = {2013-11-12T21:54:34GMT},
date-modified = {2014-11-25T12:02:01GMT},
url = {http://www.scopus.com/scopus/record/display.url?fedsrfIntegrator=MEKPAPERS-SCOCIT&origin=fedsrf&view=basic&eid=2-s2.0-33847643207},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/90/90EE29C4-3800-48AF-A88A-CCFB9A978E1A.pdf},
file = {{90EE29C4-3800-48AF-A88A-CCFB9A978E1A.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/90/90EE29C4-3800-48AF-A88A-CCFB9A978E1A.pdf:application/pdf}},
uri = {\url{papers3://publication/uuid/EA010700-C196-4CBD-B6C3-5D7CD4422610}}
}

@techreport{rdkit,
title = {{RDKit: Open-source cheminformatics}},
year = {2014},
annote = {[Online; accessed 11-April-2013]},
publisher = {http://www.rdkit.org},
rating = {0},
date-added = {2014-06-10T17:46:53GMT},
date-modified = {2015-03-26T12:22:03GMT},
url = {www.rdkit.org},
uri = {\url{papers3://publication/uuid/4C2B0E0B-5C6A-4674-BF5B-86EE825A57C2}}
}

@article{Yeh:2009fd,
author = {Yeh, Pamela J and Hegreness, Matthew J and Aiden, Aviva Presser and Kishony, Roy},
title = {{Drug interactions and the evolution of antibiotic resistance.}},
journal = {Nature reviews. Microbiology},
year = {2009},
volume = {7},
number = {6},
pages = {460--466},
month = jun,
affiliation = {Department of Systems Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.},
doi = {10.1038/nrmicro2133},
pmid = {19444248},
pmcid = {PMC2855488},
language = {English},
read = {Yes},
rating = {0},
date-added = {2014-01-29T16:58:19GMT},
date-modified = {2014-11-25T17:14:28GMT},
abstract = {Large-scale, systems biology approaches now allow us to systematically map synergistic and antagonistic interactions between drugs. Consequently, drug antagonism is emerging as a powerful tool to study biological function and relatedness between cellular components as well as to uncover mechanisms of drug action. Furthermore, theoretical models and new experiments suggest that antagonistic interactions between antibiotics can counteract the evolution of drug resistance.},
url = {http://www.nature.com/doifinder/10.1038/nrmicro2133},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/0C/0C7F8CDA-D625-4254-80B0-25AA187A7067.pdf},
file = {{0C7F8CDA-D625-4254-80B0-25AA187A7067.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/0C/0C7F8CDA-D625-4254-80B0-25AA187A7067.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1038/nrmicro2133}}
}

@book{Tukey:1977uy,
author = {Tukey, John W},
title = {{Exploratory Data Analysis}},
publisher = {Addison-Wesley},
year = {1977},
isbn = {978-0201076165},
rating = {0},
date-added = {2014-11-19T14:59:08GMT},
date-modified = {2014-12-05T14:58:22GMT},
url = {http://www.worldcat.org/title/exploratory-data-analysis/oclc/3058187},
uri = {\url{papers3://publication/uuid/D4464967-3D61-4A3E-87A0-A9F5F8ED9C08}}
}

@article{Zimmermann:2007iz,
author = {Zimmermann, Grant R and Keith, Curtis T and Leh{\'a}r, Joseph},
title = {{Multi-target therapeutics: when the whole is greater than the sum of the parts}},
journal = {Drug Discovery Today},
year = {2007},
volume = {12},
number = {1-2},
pages = {34--42},
month = jan,
annote = {Intro:
Single molecule treatments not effective due to redundancy and drug-mitigating responses such as metabolism.
        
Instead, use combinations of drugs to attack system from multiple angles.
        
This approach has been employed using drugs developed to work by themselves (monotherapy).  This is a waste of resources.
        
Rationale for multi-target therapeutics:
        
Disease state has changes in expression in multiple pathways, which each require correcting.
        
This is hard to do by influencing a single target, so modulation of multiple targets might be required to achieve optimal therapeutic benefit.
e.g. Cancer MUST be modulation of multiple targets as 4-7 mutations are required.},
keywords = {recommended by Andreas},
doi = {10.1016/j.drudis.2006.11.008},
pmid = {17198971},
language = {English},
read = {Yes},
rating = {0},
date-added = {2013-11-11T23:47:41GMT},
date-modified = {2014-11-25T17:20:03GMT},
abstract = {Drugs designed to act against individual molecular targets cannot usually combat multigenic diseases such as cancer, or diseases that affect multiple tissues or cell types such as diabetes and immunoinflammatory disorders. Combination drugs that impact multiple targets simultaneously are better at controlling complex disease systems, are less prone to drug resistance and are the standard of care in many important therapeutic areas. The combination drugs currently employed are primarily of rational design, but the increased efficacy they provide justifies in vitro discovery efforts for identifying novel multi-target mechanisms. In this review, we discuss the biological rationale for combination therapeutics, review some existing combination drugs and present a systematic approach to identify interactions between molecular pathways that could be leveraged for therapeutic benefit.},
url = {http://linkinghub.elsevier.com/retrieve/pii/S1359644606004697},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/3A/3A4545B5-ED44-46D3-9A2F-D7177E6A0029/3A4545B5-ED44-46D3-9A2F-D7177E6A0029.pdf},
file = {{3A4545B5-ED44-46D3-9A2F-D7177E6A0029.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/3A/3A4545B5-ED44-46D3-9A2F-D7177E6A0029/3A4545B5-ED44-46D3-9A2F-D7177E6A0029.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1016/j.drudis.2006.11.008}}
}

@article{Pon:2010hj,
author = {Guo, An Chi and Knox, C and Wishart, David S and Pon, Allison and Law, V and Banco, Kelly and Jewison, T and Mak, Christine and Neveu, Vanessa and Liu, P and Djoumbou, Yannick and Ly, S and Frolkis, A and Eisner, Roman and Pon, A and Banco, K and Mak, C and Neveu, V and Djoumbou, Y and Eisner, R and Guo, A C and Wishart, D S},
title = {{DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs}},
journal = {Nucleic Acids Research},
year = {2010},
volume = {39},
number = {Database},
pages = {D1035--D1041},
month = dec,
keywords = {Drug Bank},
doi = {10.1093/nar/gkq1126},
language = {English},
rating = {0},
date-added = {2013-11-11T23:40:22GMT},
date-modified = {2014-11-25T12:16:07GMT},
url = {http://nar.oxfordjournals.org/lookup/doi/10.1093/nar/gkq1126},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/1F/1FE6D21A-67CC-4D12-96AD-00D212C5B3A4.0:%20a%20comprehensive%20resource%20for%20'Omics'%20research%20on%20drugs/1FE6D21A-67CC-4D12-96AD-00D212C5B3A4.0:%20a%20comprehensive%20resource%20for%20'Omics'%20research%20on%20drugs.pdf},
file = {{1FE6D21A-67CC-4D12-96AD-00D212C5B3A4.0: a comprehensive resource for 'Omics' research on drugs.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/1F/1FE6D21A-67CC-4D12-96AD-00D212C5B3A4.0: a comprehensive resource for 'Omics' research on drugs/1FE6D21A-67CC-4D12-96AD-00D212C5B3A4.0: a comprehensive resource for 'Omics' research on drugs.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1093/nar/gkq1126}}
}

@article{Hill:2013eq,
author = {Hill, Jessica a and Nislow, Corey and Ammar, Ron and Torti, Dax and Cowen, Leah E},
title = {{Genetic and Genomic Architecture of the Evolution of Resistance to Antifungal Drug Combinations}},
journal = {PLoS Genetics},
year = {2013},
volume = {9},
number = {4},
pages = {e1003390},
month = apr,
keywords = {recommended by Andreas},
doi = {10.1371/journal.pgen.1003390},
language = {English},
rating = {0},
date-added = {2013-11-11T23:41:30GMT},
date-modified = {2015-03-08T17:37:17GMT},
url = {http://dx.plos.org/10.1371/journal.pgen.1003390},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/43/43AE01D5-5727-46AB-9A1B-35CF03875457/43AE01D5-5727-46AB-9A1B-35CF03875457.pdf},
file = {{43AE01D5-5727-46AB-9A1B-35CF03875457.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/43/43AE01D5-5727-46AB-9A1B-35CF03875457/43AE01D5-5727-46AB-9A1B-35CF03875457.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1371/journal.pgen.1003390}}
}

@article{Costello:2014gh,
author = {Costello, James C and Heiser, Laura M and Georgii, Elisabeth and G{\"o}nen, Mehmet and Menden, Michael P and Wang, Nicholas J and Bansal, Mukesh and Ammad-Ud-Din, Muhammad and Hintsanen, Petteri and Khan, Suleiman A and Mpindi, John-Patrick and Kallioniemi, Olli and Honkela, Antti and Aittokallio, Tero and Wennerberg, Krister and {NCI DREAM Community} and Collins, James J and Gallahan, Dan and Singer, Dinah and Saez-Rodriguez, Julio and Kaski, Samuel and Gray, Joe W and Stolovitzky, Gustavo},
title = {{A community effort to assess and improve drug sensitivity prediction algorithms.}},
journal = {Nature Biotechnology},
year = {2014},
month = jun,
affiliation = {1] Howard Hughes Medical Institute, Boston University, Boston, Massachusetts, USA. [2] Department of Biomedical Engineering, Boston University, Boston, Massachusetts, USA. [3] [4].},
doi = {10.1038/nbt.2877},
pmid = {24880487},
language = {English},
read = {Yes},
rating = {0},
date-added = {2014-11-25T15:59:07GMT},
date-modified = {2014-11-25T17:34:06GMT},
abstract = {Predicting the best treatment strategy from genomic information is a core goal of precision medicine. Here we focus on predicting drug response based on a cohort of genomic, epigenomic and proteomic profiling data sets measured in human breast cancer cell lines. Through a collaborative effort between the National Cancer Institute (NCI) and the Dialogue on Reverse Engineering Assessment and Methods (DREAM) project, we analyzed a total of 44 drug sensitivity prediction algorithms. The top-performing approaches modeled nonlinear relationships and incorporated biological pathway information. We found that gene expression microarrays consistently provided the best predictive power of the individual profiling data sets; however, performance was increased by including multiple, independent data sets. We discuss the innovations underlying the top-performing methodology, Bayesian multitask MKL, and we provide detailed descriptions of all methods. This study establishes benchmarks for drug sensitivity prediction and identifies approaches that can be leveraged for the development of new methods.},
url = {http://www.nature.com/doifinder/10.1038/nbt.2877},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/6F/6FBC1471-3529-4FCB-ABB1-0669886CFB50.pdf},
file = {{6FBC1471-3529-4FCB-ABB1-0669886CFB50.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/6F/6FBC1471-3529-4FCB-ABB1-0669886CFB50.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1038/nbt.2877}}
}

@article{ChemAxon:2013ti,
author = {ChemAxon},
title = {{Standardizer}},
year = {2013},
publisher = {ChemAxon},
rating = {0},
date-added = {2013-11-11T23:50:55GMT},
date-modified = {2015-03-09T02:44:37GMT},
url = {http://www.mendeley.com/research/standardizer/},
uri = {\url{papers3://publication/uuid/6A5D9BCC-8657-4969-AF93-3B8AED864E82}}
}

@article{Ryall:2015hy,
author = {Ryall, R A and Tan, A C},
title = {{Systems biology approaches for advancing the discovery of effective drug combinations}},
year = {2015},
volume = {7},
number = {1},
pages = {7},
month = feb,
publisher = {Chemistry Central Ltd},
doi = {10.1186/s13321-015-0055-9},
language = {English},
rating = {0},
date-added = {2015-03-26T12:14:40GMT},
date-modified = {2015-03-26T12:17:04GMT},
abstract = {Complex diseases like cancer are regulated by large, interconnected networks with many pathways affecting cell proliferation, invasion, and drug resistance. However, current cancer therapy predominantly relies on the reductionist approach of one gene-one disease. Combinations of drugs may overcome drug resistance by limiting mutations and induction of escape pathways, but given the enormous number of possible drug combinations, strategies to reduce the search space and prioritize experiments are needed. In this review, we focus on the use of computational modeling, bioinformatics and high-throughput experimental methods for discovery of drug combinations. We highlight cutting-edge systems approaches, including large-scale modeling of cell signaling networks, network motif analysis, statistical association-based models, identifying correlations in gene signatures, functional genomics, and high-throughput combination screens. We also present a list of publicly available data and resources to aid in discovery of drug combinations. Integration of these systems approaches will enable faster discovery and translation of clinically relevant drug combinations.},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/26/26F32405-37F4-45A3-B821-F445031A583A.pdf},
file = {{26F32405-37F4-45A3-B821-F445031A583A.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/26/26F32405-37F4-45A3-B821-F445031A583A.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1186/s13321-015-0055-9}}
}

@article{Zhao:2011ja,
author = {Zhao, Xing-Ming and Iskar, Murat and Zeller, Georg and Kuhn, Michael and Van Noort, Vera and Bork, Peer},
title = {{Prediction of Drug Combinations by Integrating Molecular and Pharmacological Data}},
journal = {PLoS Computational Biology},
year = {2011},
volume = {7},
number = {12},
pages = {e1002323},
month = dec,
keywords = {recommended by Andreas},
doi = {10.1371/journal.pcbi.1002323},
pmid = {22219721},
pmcid = {PMC3248384},
language = {English},
read = {Yes},
rating = {0},
date-added = {2013-11-11T23:50:07GMT},
date-modified = {2015-03-08T18:01:03GMT},
url = {http://dx.plos.org/10.1371/journal.pcbi.1002323},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/B0/B0A5F17E-9B25-4AD4-9A70-590E4C9C4547/B0A5F17E-9B25-4AD4-9A70-590E4C9C4547.pdf},
file = {{B0A5F17E-9B25-4AD4-9A70-590E4C9C4547.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/B0/B0A5F17E-9B25-4AD4-9A70-590E4C9C4547/B0A5F17E-9B25-4AD4-9A70-590E4C9C4547.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1371/journal.pcbi.1002323}}
}

@article{Bender:2006ub,
author = {Bender, A and Jenkins, J L and Glick, M and Zhan, D and Nettles, J H and Davies, J W},
title = {{"Bayes affinity fingerprints" Improve retrieval rates in virtual screening and define orthogonal bioactivity space: When are multitarget drugs a feasible concept?}},
journal = {Journal of Chemical Information and Modeling},
year = {2006},
volume = {46},
number = {6},
pages = {2445--2456},
read = {Yes},
rating = {0},
date-added = {2013-12-17T11:45:26GMT},
date-modified = {2015-03-26T12:22:03GMT},
url = {http://www.scopus.com/scopus/record/display.url?fedsrfIntegrator=MEKPAPERS-SCOCIT&origin=fedsrf&view=basic&eid=2-s2.0-33750986884},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/1F/1FDAFC9B-2583-405E-A921-B14C351FB32F.pdf},
file = {{1FDAFC9B-2583-405E-A921-B14C351FB32F.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/1F/1FDAFC9B-2583-405E-A921-B14C351FB32F.pdf:application/pdf}},
uri = {\url{papers3://publication/uuid/E858C318-F904-44FA-A815-373FF78A9EFD}}
}

@article{Gaulton:2011ix,
author = {Gaulton, A and Bellis, L J and Bento, A P and Chambers, J and Davies, M and Hersey, A and Light, Y and McGlinchey, S and Michalovich, D and Al-Lazikani, B and Overington, J P},
title = {{ChEMBL: a large-scale bioactivity database for drug discovery}},
journal = {Nucleic Acids Research},
year = {2011},
volume = {40},
number = {D1},
pages = {D1100--D1107},
month = dec,
keywords = {ChEMBL},
doi = {10.1093/nar/gkr777},
language = {English},
rating = {0},
date-added = {2013-11-11T23:36:20GMT},
date-modified = {2014-11-25T20:47:15GMT},
url = {http://nar.oxfordjournals.org/lookup/doi/10.1093/nar/gkr777},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/F0/F0B57486-DC89-45B8-B55F-BB1AADF3D5C8/F0B57486-DC89-45B8-B55F-BB1AADF3D5C8.pdf},
file = {{F0B57486-DC89-45B8-B55F-BB1AADF3D5C8.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/F0/F0B57486-DC89-45B8-B55F-BB1AADF3D5C8/F0B57486-DC89-45B8-B55F-BB1AADF3D5C8.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1093/nar/gkr777}}
}

@article{Cokol:2011ck,
author = {Cokol, Murat and Chua, Hon Nian and Tasan, Murat and Mutlu, Beste and Weinstein, Zohar B and Suzuki, Yo and Nergiz, Mehmet E and Costanzo, Michael and Baryshnikova, Anastasia and Giaever, Guri and Nislow, Corey and Myers, Chad L and Andrews, Brenda J and Boone, Charles and Roth, Frederick P},
title = {{Systematic exploration of synergistic drug pairs}},
journal = {Molecular Systems Biology},
year = {2011},
volume = {7},
pages = {544},
month = nov,
affiliation = {Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. cokol@sabanciuniv.edu},
keywords = {recommended by Andreas},
doi = {10.1038/msb.2011.71},
pmid = {22068327},
pmcid = {PMC3261710},
language = {English},
read = {Yes},
rating = {0},
date-added = {2014-01-28T12:04:59GMT},
date-modified = {2014-11-25T16:29:41GMT},
abstract = {Drug synergy allows a therapeutic effect to be achieved with lower doses of component drugs. Drug synergy can result when drugs target the products of genes that act in parallel pathways ('specific synergy'). Such cases of drug synergy should tend to correspond to synergistic genetic interaction between the corresponding target genes. Alternatively, 'promiscuous synergy' can arise when one drug non-specifically increases the effects of many other drugs, for example, by increased bioavailability. To assess the relative abundance of these drug synergy types, we examined 200 pairs of antifungal drugs in S. cerevisiae. We found 38 antifungal synergies, 37 of which were novel. While 14 cases of drug synergy corresponded to genetic interaction, 92% of the synergies we discovered involved only six frequently synergistic drugs. Although promiscuity of four drugs can be explained under the bioavailability model, the promiscuity of Tacrolimus and Pentamidine was completely unexpected. While many drug synergies correspond to genetic interactions, the majority of drug synergies appear to result from non-specific promiscuous synergy.},
url = {http://msb.embopress.org/cgi/doi/10.1038/msb.2011.71},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/D8/D8852092-3133-4964-A4B0-0AACA713DEEC.pdf},
file = {{D8852092-3133-4964-A4B0-0AACA713DEEC.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/D8/D8852092-3133-4964-A4B0-0AACA713DEEC.pdf:application/pdf;D8852092-3133-4964-A4B0-0AACA713DEEC.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/D8/D8852092-3133-4964-A4B0-0AACA713DEEC.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1038/msb.2011.71}}
}

@article{Severyn:2011gu,
author = {Severyn, Bryan and Liehr, Robert A and Wolicki, Alex and Nguyen, Kevin H and Hudak, Edward M and Ferrer, Marc and Caldwell, Jeremy S and Hermes, Jeffrey D and Li, Jing and Tudor, Matthew},
title = {{Parsimonious discovery of synergistic drug combinations.}},
journal = {ACS Chemical Biology},
year = {2011},
volume = {6},
number = {12},
pages = {1391--1398},
month = dec,
affiliation = {Merck Research Laboratories, North Wales, Pennsylvania 19454, USA.},
doi = {10.1021/cb2003225},
pmid = {21974780},
language = {English},
read = {Yes},
rating = {0},
date-added = {2014-11-24T18:52:09GMT},
date-modified = {2014-11-25T17:21:01GMT},
abstract = {Combination therapies that enhance efficacy or permit reduced dosages to be administered have seen great success in a variety of therapeutic applications. More fundamentally, the discovery of epistatic pathway interactions not only informs pharmacologic intervention but can be used to better understand the underlying biological system. There is, however, no systematic and efficient method to identify interacting activities as candidates for combination therapy and, in particular, to identify those with synergistic activities. We devised a pooled, self-deconvoluting screening paradigm for the efficient comprehensive interrogation of all pairs of compounds in 1000-compound libraries. We demonstrate the power of the method to recover established synergistic interactions between compounds. We then applied this approach to a cell-based screen for anti-inflammatory activities using an assay for lipopolysaccharide/interferon-induced acute phase response of a monocytic cell line. The described method, which is >20 times as efficient as a na{\"\i}ve approach, was used to test all pairs of 1027 bioactive compounds for interleukin-6 suppression, yielding 11 pairs of compounds that show synergy. These 11 pairs all represent the same two activities: $\beta$-adrenergic receptor agonists and phosphodiesterase-4 inhibitors. These activities both act through cyclic AMP elevation and are known to be anti-inflammatory alone and to synergize in combination. Thus we show proof of concept for a robust, efficient technique for the identification of synergistic combinations. Such a tool can enable qualitatively new scales of pharmacological research and chemical genetics.},
url = {http://pubs.acs.org/doi/abs/10.1021/cb2003225},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/9B/9B34BE02-BFD6-4646-A9E6-7D36042863F2.pdf},
file = {{9B34BE02-BFD6-4646-A9E6-7D36042863F2.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/9B/9B34BE02-BFD6-4646-A9E6-7D36042863F2.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1021/cb2003225}}
}

@article{Bliss:1939jz,
author = {Bliss, C I},
title = {{The Toxicity of Poisons Applied Jointly}},
journal = {Annals of applied biology},
year = {1939},
volume = {26},
number = {3},
pages = {585--615},
month = aug,
publisher = {Blackwell Publishing Ltd},
doi = {10.1111/j.1744-7348.1939.tb06990.x},
language = {English},
read = {Yes},
rating = {0},
date-added = {2014-07-16T21:30:20GMT},
date-modified = {2014-11-21T16:51:43GMT},
abstract = {... A quantitative analysis of the toxicity of drugs or poisons  applied  jointly requires that they be administered at ... correlated with that to the other, mixtures in this category are more toxic than in ... to 1. The numerical relations have been illustrated by an experiment on the toxicity to the ... 
},
url = {http://doi.wiley.com/10.1111/j.1744-7348.1939.tb06990.x},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/CC/CC9B18EB-E180-4F20-BDE8-D50726F8EE8E.pdf},
file = {{CC9B18EB-E180-4F20-BDE8-D50726F8EE8E.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/CC/CC9B18EB-E180-4F20-BDE8-D50726F8EE8E.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1111/j.1744-7348.1939.tb06990.x}}
}

@article{Berenbaum:1989tz,
author = {Berenbaum, M C},
title = {{What is synergy?}},
journal = {Pharmacological Reviews},
year = {1989},
volume = {41},
number = {2},
pages = {93--141},
affiliation = {Department of Experimental Pathology, St. Mary's Hospital Medical School, London, United Kingdom.},
pmid = {2692037},
language = {English},
read = {Yes},
rating = {0},
date-added = {2014-01-07T17:56:44GMT},
date-modified = {2014-12-05T15:47:56GMT},
url = {http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=2692037&retmode=ref&cmd=prlinks},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/51/5105FDA8-E444-484D-A5A6-2AE1D6D0CCF8.pdf},
file = {{5105FDA8-E444-484D-A5A6-2AE1D6D0CCF8.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/51/5105FDA8-E444-484D-A5A6-2AE1D6D0CCF8.pdf:application/pdf}},
uri = {\url{papers3://publication/uuid/C852C506-9285-4E5A-8F04-B9FFF5E8729F}}
}

@inproceedings{Methodology:Vo2u6pM-,
author = {Methodology, WHO Collaborating Centre for Drug Statistics},
title = {{Guidelines for ATC classification and DDD assignment, 2015.}},
booktitle = {Oslo},
rating = {0},
date-added = {2015-03-08T18:10:34GMT},
date-modified = {2015-03-08T18:11:47GMT},
uri = {\url{papers3://publication/uuid/568DAEEA-933E-4B72-9EEE-3FF2451486BA}}
}

@article{Hunter:2007ux,
author = {Hunter, J D},
title = {{Matplotlib: A 2D graphics environment}},
journal = {Computing in Science and Engineering},
year = {2007},
volume = {9},
number = {3},
pages = {99--104},
read = {Yes},
rating = {0},
date-added = {2014-06-09T17:17:49GMT},
date-modified = {2015-03-09T01:55:49GMT},
url = {http://www.scopus.com/scopus/record/display.url?fedsrfIntegrator=MEKPAPERS-SCOCIT&origin=fedsrf&view=basic&eid=2-s2.0-34247493236},
uri = {\url{papers3://publication/uuid/1D3FB11D-6F18-46AD-9D5B-0D1B8F0289D7}}
}

@article{malaria-paper,
author = {Guha, Rajarshi},
title = {{Malaria Paper}},
rating = {0},
date-added = {2014-12-08T16:08:06GMT},
date-modified = {2014-12-08T16:08:39GMT},
uri = {\url{papers3://publication/uuid/B0EA68CB-1E8C-4844-AD61-38FECDF6186B}}
}

@article{Pallavi:2010ge,
author = {Pallavi, Rani and Roy, Nainita and Nageshan, Rishi Kumar and Talukdar, Pinaki and Pavithra, Soundara Raghavan and Reddy, Raghunath and Venketesh, S and Kumar, Rajender and Gupta, Ashok Kumar and Singh, Raj Kumar and Yadav, Suresh Chandra and Tatu, Utpal},
title = {{Heat shock protein 90 as a drug target against protozoan infections: biochemical characterization of HSP90 from Plasmodium falciparum and Trypanosoma evansi and evaluation of its inhibitor as a candidate drug.}},
journal = {The Journal of biological chemistry},
year = {2010},
volume = {285},
number = {49},
pages = {37964--37975},
month = dec,
publisher = {American Society for Biochemistry and Molecular Biology},
affiliation = {Department of Biochemistry, Indian Institute of Science, Bangalore, Karnataka 560012, India.},
doi = {10.1074/jbc.M110.155317},
pmid = {20837488},
pmcid = {PMC2992230},
language = {English},
read = {Yes},
rating = {0},
date-added = {2014-12-08T16:27:30GMT},
date-modified = {2015-02-18T14:36:04GMT},
abstract = {Using a pharmacological inhibitor of Hsp90 in cultured malarial parasite, we have previously implicated Plasmodium falciparum Hsp90 (PfHsp90) as a drug target against malaria. In this study, we have biochemically characterized PfHsp90 in terms of its ATPase activity and interaction with its inhibitor geldanamycin (GA) and evaluated its potential as a drug target in a preclinical mouse model of malaria. In addition, we have explored the potential of Hsp90 inhibitors as drugs for the treatment of Trypanosoma infection in animals. Our studies with full-length PfHsp90 showed it to have the highest ATPase activity of all known Hsp90s; its ATPase activity was 6 times higher than that of human Hsp90. Also, GA brought about more robust inhibition of PfHsp90 ATPase activity as compared with human Hsp90. Mass spectrometric analysis of PfHsp90 expressed in P. falciparum identified a site of acetylation that overlapped with Aha1 and p23 binding domain, suggesting its role in modulating Hsp90 multichaperone complex assembly. Indeed, treatment of P. falciparum cultures with a histone deacetylase inhibitor resulted in a partial dissociation of PfHsp90 complex. Furthermore, we found a well known, semisynthetic Hsp90 inhibitor, namely 17-(allylamino)-17-demethoxygeldanamycin, to be effective in attenuating parasite growth and prolonging survival in a mouse model of malaria. We also characterized GA binding to Hsp90 from another protozoan parasite, namely Trypanosoma evansi. We found 17-(allylamino)-17-demethoxygeldanamycin to potently inhibit T. evansi growth in a mouse model of trypanosomiasis. In all, our biochemical characterization, drug interaction, and animal studies supported Hsp90 as a drug target and its inhibitor as a potential drug against protozoan diseases.},
url = {http://www.jbc.org/content/285/49/37964.full},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/F2/F26E386E-6B08-4873-B4A1-ACC91F366660.pdf},
file = {{F26E386E-6B08-4873-B4A1-ACC91F366660.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/F2/F26E386E-6B08-4873-B4A1-ACC91F366660.pdf:application/pdf;F26E386E-6B08-4873-B4A1-ACC91F366660.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/F2/F26E386E-6B08-4873-B4A1-ACC91F366660.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1074/jbc.M110.155317}}
}

@article{Wishart:2007bb,
author = {Wishart, D S and Knox, C and Guo, A C and Cheng, D and Shrivastava, S and Tzur, D and Gautam, B and Hassanali, M},
title = {{DrugBank: a knowledgebase for drugs, drug actions and drug targets}},
journal = {Nucleic Acids Research},
year = {2007},
volume = {36},
number = {Database},
pages = {D901--D906},
month = dec,
keywords = {Drug Bank},
doi = {10.1093/nar/gkm958},
pmid = {18048412},
pmcid = {PMC2238889},
language = {English},
read = {Yes},
rating = {0},
date-added = {2013-11-11T23:39:57GMT},
date-modified = {2014-11-25T17:22:11GMT},
url = {http://nar.oxfordjournals.org/lookup/doi/10.1093/nar/gkm958},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/64/647732A7-1CD7-46C7-9EDF-E15EA907FE4F/647732A7-1CD7-46C7-9EDF-E15EA907FE4F.pdf},
file = {{647732A7-1CD7-46C7-9EDF-E15EA907FE4F.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/64/647732A7-1CD7-46C7-9EDF-E15EA907FE4F/647732A7-1CD7-46C7-9EDF-E15EA907FE4F.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1093/nar/gkm958}}
}

@article{Yilancioglu:2014gd,
author = {Yilancioglu, Kaan and Weinstein, Zohar B and Meydan, Cem and Akhmetov, Azat and Toprak, Isil and Durmaz, Arda and Iossifov, Ivan and Kazan, Hilal and Roth, Frederick P and Cokol, Murat},
title = {{Target-independent prediction of drug synergies using only drug lipophilicity.}},
journal = {Journal of Chemical Information and Modeling},
year = {2014},
pages = {140715122131000},
month = jul,
keywords = {Lipophilicity Paper},
doi = {10.1021/ci500276x},
pmid = {25026390},
pmcid = {PMC4144720},
language = {English},
read = {Yes},
rating = {0},
date-added = {2014-08-01T15:49:59GMT},
date-modified = {2014-11-21T16:51:34GMT},
abstract = {Physicochemical properties of compounds have been instrumental in selecting lead compounds with increased drug-likeness. However, the relationship between physicochemical properties of constituent drugs and the tendency to exhibit drug interaction has not been systematically studied. We assembled physicochemical descriptors for a set of anti-fungal compounds ('drugs') previously examined for interaction. Analyzing the relationship between molecular weight, lipophilicity, H-bond donor and H-bond acceptor values for drugs and their propensity to show pairwise antifungal drug synergy, we found that combinations of two lipophilic drugs had a greater tendency to show drug synergy. We developed a more refined decision tree model that successfully predicted drug synergy in stringent cross-validation tests based on only lipophilicity of drugs. Our predictions achieved a precision of 63%, and allowed successful prediction for 58% of synergistic drug pairs, suggesting that this phenomenon can extend our understanding for a substantial fraction of synergistic drug interactions. We also generated and analyzed a large-scale synergistic human toxicity network, in which we observed that combinations of lipophilic compounds show a tendency for increased toxicity. Thus, lipophilicity, a simple and easily-determined molecular descriptor, is a powerful predictor of drug synergy. It is well established that lipophilic compounds (i) are promiscuous; having many targets in the cell and (ii) often penetrate into the cell via the cellular membrane by passive diffusion. We discuss the positive relationship between drug lipophilicity and drug synergy in the context of potential drug synergy mechanisms.},
url = {http://pubs.acs.org/doi/abs/10.1021/ci500276x},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/BB/BB931674-4A60-45F4-B94F-9CCFDB03AF4B.pdf},
file = {{BB931674-4A60-45F4-B94F-9CCFDB03AF4B.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/BB/BB931674-4A60-45F4-B94F-9CCFDB03AF4B.pdf:application/pdf;BB931674-4A60-45F4-B94F-9CCFDB03AF4B.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/BB/BB931674-4A60-45F4-B94F-9CCFDB03AF4B.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1021/ci500276x}}
}

@article{Bansal:2014gh,
author = {Bansal, Mukesh and Yang, Jichen and Karan, Charles and Menden, Michael P and Costello, James C and Tang, Hao and Xiao, Guanghua and Li, Yajuan and Allen, Jeffrey and Zhong, Rui and Chen, Beibei and Kim, Minsoo and Wang, Tao and Heiser, Laura M and Realubit, Ronald and Mattioli, Michela and Alvarez, Mariano J and Shen, Yao and {NCI DREAM Community} and Gallahan, Daniel and Singer, Dinah and Saez-Rodriguez, Julio and Xie, Yang and Stolovitzky, Gustavo and Califano, Andrea},
title = {{A community computational challenge to predict the activity of pairs of compounds.}},
journal = {Nature Biotechnology},
year = {2014},
month = nov,
affiliation = {1] Department of Systems Biology, Columbia University, New York, New York, USA. [2] Center for Computational Biology and Bioinformatics, Columbia University, New York, New York, USA.},
doi = {10.1038/nbt.3052},
pmid = {25419740},
language = {English},
rating = {0},
date-added = {2014-11-25T16:02:37GMT},
date-modified = {2014-11-25T17:34:06GMT},
abstract = {Recent therapeutic successes have renewed interest in drug combinations, but experimental screening approaches are costly and often identify only small numbers of synergistic combinations. The DREAM consortium launched an open challenge to foster the development of in silico methods to computationally rank 91 compound pairs, from the most synergistic to the most antagonistic, based on gene-expression profiles of human B cells treated with individual compounds at multiple time points and concentrations. Using scoring metrics based on experimental dose-response curves, we assessed 32 methods (31 community-generated approaches and SynGen), four of which performed significantly better than random guessing. We highlight similarities between the methods. Although the accuracy of predictions was not optimal, we find that computational prediction of compound-pair activity is possible, and that community challenges can be useful to advance the field of in silico compound-synergy prediction.},
url = {http://www.nature.com/doifinder/10.1038/nbt.3052},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/E5/E5ABC329-D2A4-4639-BE9B-2320A17AB001.pdf},
file = {{E5ABC329-D2A4-4639-BE9B-2320A17AB001.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/E5/E5ABC329-D2A4-4639-BE9B-2320A17AB001.pdf:application/pdf;E5ABC329-D2A4-4639-BE9B-2320A17AB001.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/E5/E5ABC329-D2A4-4639-BE9B-2320A17AB001.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1038/nbt.3052}}
}

@article{Marfurt:2011fd,
author = {Marfurt, Jutta and Chalfein, Ferryanto and Prayoga, Pak and Wabiser, Frans and Kenangalem, Enny and Piera, Kim A and Fairlie, David P and Tjitra, Emiliana and Anstey, Nicholas M and Andrews, Kathy T and Price, Ric N},
title = {{Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax.}},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2011},
volume = {55},
number = {3},
pages = {961--966},
month = mar,
publisher = {American Society for Microbiology},
affiliation = {Menzies School of Health Research, P.O. Box 41096, Casuarina, Darwin, NT 0811, Australia.},
doi = {10.1128/AAC.01220-10},
pmid = {21135175},
pmcid = {PMC3067106},
language = {English},
read = {Yes},
rating = {0},
date-added = {2014-11-25T18:25:27GMT},
date-modified = {2014-12-03T15:59:00GMT},
abstract = {Histone acetylation plays an important role in regulating gene transcription and silencing in Plasmodium falciparum. Histone deacetylase (HDAC) inhibitors, particularly those of the hydroxamate class, have been shown to have potent in vitro activity against drug-resistant and -sensitive laboratory strains of P. falciparum, raising their potential as a new class of antimalarial compounds. In the current study, stage-specific ex vivo susceptibility profiles of representative hydroxamate-based HDAC inhibitors suberoylanilide hydroxamic acid (SAHA), 2-ASA-9, and 2-ASA-14 (2-ASA-9 and 2-ASA-14 are 2-aminosuberic acid-based HDAC inhibitors) were assessed in multidrug-resistant clinical isolates of P. falciparum (n = 24) and P. vivax (n = 25) from Papua, Indonesia, using a modified schizont maturation assay. Submicromolar concentrations of SAHA, 2-ASA-9, and 2-ASA-14 inhibited the growth of both P. falciparum (median 50% inhibitory concentrations [ICs] of 310, 533, and 266 nM) and P. vivax (median ICs of 170, 503, and 278 nM). Inverse correlation patterns between HDAC inhibitors and chloroquine for P. falciparum and mefloquine for P. vivax indicate species-specific susceptibility profiles for HDAC inhibitors. These HDAC inhibitors were also found to be potent ex vivo against P. vivax schizont maturation, comparable to that in P. falciparum, suggesting that HDAC inhibitors may be promising candidates for antimalarial therapy in geographical locations where both species are endemic. Further studies optimizing the selectivity and in vivo efficacy of HDAC inhibitors in Plasmodium spp. and defining drug interaction with common antimalarial compounds are warranted to investigate the role of HDAC inhibitors in antimalarial therapy.},
url = {http://aac.asm.org/content/55/3/961.full},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/6C/6CB0DFE4-C996-47A0-88A6-35F90083A441.pdf},
file = {{6CB0DFE4-C996-47A0-88A6-35F90083A441.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/6C/6CB0DFE4-C996-47A0-88A6-35F90083A441.pdf:application/pdf;6CB0DFE4-C996-47A0-88A6-35F90083A441.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/6C/6CB0DFE4-C996-47A0-88A6-35F90083A441.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1128/AAC.01220-10}}
}

@article{Greco:1995ud,
author = {Greco, W R and Bravo, G and Parsons, J C},
title = {{The search for synergy: A critical review from a response surface perspective}},
journal = {Pharmacological Reviews},
year = {1995},
volume = {47},
number = {2},
pages = {331--385},
read = {Yes},
rating = {0},
date-added = {2013-12-17T17:14:59GMT},
date-modified = {2015-03-26T12:22:03GMT},
url = {http://pubget.com/site/paper/7568331?institution=cam.ac.uk},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/CD/CDC930C4-4568-417B-985F-9065D9A4A350.pdf},
file = {{CDC930C4-4568-417B-985F-9065D9A4A350.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/CD/CDC930C4-4568-417B-985F-9065D9A4A350.pdf:application/pdf}},
uri = {\url{papers3://publication/uuid/C23AB4A1-9299-4E36-B1B9-9C00A4195CE1}}
}

@article{Griner:2014gb,
author = {Griner, Lesley A Mathews and Guha, Rajarshi and Shinn, Paul and Young, Ryan M and Keller, Jonathan M and Liu, Dongbo and Goldlust, Ian S and Yasgar, Adam and McKnight, Crystal and Boxer, Matthew B and Duveau, Damien Y and Jiang, Jian-Kang and Michael, Sam and Mierzwa, Tim and Huang, Wenwei and Walsh, Martin J and Mott, Bryan T and Patel, Paresma and Leister, William and Maloney, David J and Leclair, Christopher A and Rai, Ganesha and Jadhav, Ajit and Peyser, Brian D and Austin, Christopher P and Martin, Scott E and Simeonov, Anton and Ferrer, Marc and Staudt, Louis M and Thomas, Craig J},
title = {{High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell{\textendash}like diffuse large B-cell lymphoma cells}},
journal = {Proceedings of the National Academy of Sciences},
year = {2014},
pages = {201311846},
month = jan,
publisher = {National Acad Sciences},
keywords = {Bliss, Gaddum, Loewe},
doi = {10.1073/pnas.1311846111},
language = {English},
read = {Yes},
rating = {0},
date-added = {2014-01-28T10:07:33GMT},
date-modified = {2014-11-21T16:33:07GMT},
abstract = {The clinical development of drug combinations is typically achieved through trial-and-error or via insight gained through a detailed molecular understanding of dysregulated signaling pathways in a specific cancer type. Unbiased small-molecule combination (matrix) screening represents a high-throughput means to explore hundreds and even thousands of drug{\textendash}drug pairs for potential investigation and translation. Here, we describe a high-throughput screening plat- form capable of testing compounds in pairwise matrix blocks for the rapid and systematic identification of synergistic, additive, and antag- onistic drug combinations. We use this platform to define potential therapeutic combinations for the activated B-cell{\textendash}like subtype (ABC) of diffuse large B-cell lymphoma (DLBCL). We identify drugs with synergy, additivity, and antagonism with the Bruton{\textquoteright}s tyrosine kinase inhibitor ibrutinib, which targets the chronic active B-cell receptor signaling that characterizes ABC DLBCL. Ibrutinib interacted favorably with a wide range of compounds, including inhibitors of the PI3K- AKT-mammalian target of rapamycin signaling cascade, other B-cell receptor pathway inhibitors, Bcl-2 family inhibitors, and several com- ponents of chemotherapy that is the standard of care for DLBCL},
url = {http://www.pnas.org/cgi/doi/10.1073/pnas.1311846111},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/20/20DBD4DD-AF24-40F3-96D0-1C11CFE0148F.pdf},
file = {{20DBD4DD-AF24-40F3-96D0-1C11CFE0148F.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/20/20DBD4DD-AF24-40F3-96D0-1C11CFE0148F.pdf:application/pdf;20DBD4DD-AF24-40F3-96D0-1C11CFE0148F.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/20/20DBD4DD-AF24-40F3-96D0-1C11CFE0148F.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1073/pnas.1311846111}}
}

@techreport{Anonymous:2012PR,
title = {{Visualization Prospect - Merck Molecular Activity Challenge}},
year = {2012},
month = oct,
read = {Yes},
rating = {0},
date-added = {2014-11-06T16:48:25GMT},
date-modified = {2014-11-21T16:28:47GMT},
url = {https://www.kaggle.com/c/MerckActivity/details/visualization-prospect},
uri = {\url{papers3://publication/uuid/BD70A8CE-63D1-4369-82CB-7F043B0D7EBC}}
}

@article{Krueger:2009fm,
author = {Krueger, Andrew S and Avery, William and Heilbut, Adrian M and Johansen, Lisa M and Price, E Roydon and Rickles, Richard J and Short, Glenn F and Staunton, Jane E and Jin, Xiaowei and Lee, Margaret S and Zimmermann, Grant R and Borisy, Alexis a and Leh{\'a}r, Joseph},
title = {{Synergistic drug combinations tend to improve therapeutically relevant selectivity.}},
journal = {Nature Biotechnology},
year = {2009},
volume = {27},
number = {7},
pages = {659--666},
month = jul,
affiliation = {CombinatoRx Inc., Cambridge, Massachusetts, USA.},
keywords = {recommended by Andreas, Six diseases dataset},
doi = {10.1038/nbt.1549},
pmid = {19581876},
pmcid = {PMC2708317},
language = {English},
read = {Yes},
rating = {0},
date-added = {2013-11-11T23:52:18GMT},
date-modified = {2014-11-25T12:28:32GMT},
abstract = {Drug combinations are a promising strategy to overcome the compensatory mechanisms and unwanted off-target effects that limit the utility of many potential drugs. However, enthusiasm for this approach is tempered by concerns that the therapeutic synergy of a combination will be accompanied by synergistic side effects. Using large scale simulations of bacterial metabolism and 94,110 multi-dose experiments relevant to diverse diseases, we provide evidence that synergistic drug combinations are generally more specific to particular cellular contexts than are single agent activities. We highlight six combinations whose selective synergy depends on multitarget drug activity. For one anti-inflammatory example, we show how such selectivity is achieved through differential expression of the drugs' targets in cell types associated with therapeutic, but not toxic, effects and validate its therapeutic relevance in a rat model of asthma. The context specificity of synergistic combinations creates many opportunities for therapeutically relevant selectivity and enables improved control of complex biological systems.},
url = {http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=19581876&retmode=ref&cmd=prlinks},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/89/89DBE352-3608-42F4-89D0-BCBD0667DE57/89DBE352-3608-42F4-89D0-BCBD0667DE57.pdf},
file = {{89DBE352-3608-42F4-89D0-BCBD0667DE57.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/89/89DBE352-3608-42F4-89D0-BCBD0667DE57/89DBE352-3608-42F4-89D0-BCBD0667DE57.pdf:application/pdf;89DBE352-3608-42F4-89D0-BCBD0667DE57.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/89/89DBE352-3608-42F4-89D0-BCBD0667DE57/89DBE352-3608-42F4-89D0-BCBD0667DE57.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1038/nbt.1549}}
}

@article{Nelander:2008ji,
author = {Nelander, Sven and Wang, Weiqing and Nilsson, Bj{\"o}rn and She, Qing-Bai and Pratilas, Christine and Rosen, Neal and Gennemark, Peter and Sander, Chris},
title = {{Models from experiments: combinatorial drug perturbations of cancer cells.}},
journal = {Molecular Systems Biology},
year = {2008},
volume = {4},
pages = {216},
affiliation = {Computational Biology center, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. multiple-perturbation@cbio.mskcc.org},
keywords = {MCF7 dataset, recommended by Andreas},
doi = {10.1038/msb.2008.53},
pmid = {18766176},
pmcid = {PMC2564730},
language = {English},
read = {Yes},
rating = {0},
date-added = {2013-11-11T23:46:52GMT},
date-modified = {2014-11-25T17:20:23GMT},
abstract = {We present a novel method for deriving network models from molecular profiles of perturbed cellular systems. The network models aim to predict quantitative outcomes of combinatorial perturbations, such as drug pair treatments or multiple genetic alterations. Mathematically, we represent the system by a set of nodes, representing molecular concentrations or cellular processes, a perturbation vector and an interaction matrix. After perturbation, the system evolves in time according to differential equations with built-in nonlinearity, similar to Hopfield networks, capable of representing epistasis and saturation effects. For a particular set of experiments, we derive the interaction matrix by minimizing a composite error function, aiming at accuracy of prediction and simplicity of network structure. To evaluate the predictive potential of the method, we performed 21 drug pair treatment experiments in a human breast cancer cell line (MCF7) with observation of phospho-proteins and cell cycle markers. The best derived network model rediscovered known interactions and contained interesting predictions. Possible applications include the discovery of regulatory interactions, the design of targeted combination therapies and the engineering of molecular biological networks.},
url = {http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=18766176&retmode=ref&cmd=prlinks},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/2D/2DB92278-36AB-48C6-B4CD-A2613B4125F8/2DB92278-36AB-48C6-B4CD-A2613B4125F8.pdf},
file = {{2DB92278-36AB-48C6-B4CD-A2613B4125F8.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/2D/2DB92278-36AB-48C6-B4CD-A2613B4125F8/2DB92278-36AB-48C6-B4CD-A2613B4125F8.pdf:application/pdf;2DB92278-36AB-48C6-B4CD-A2613B4125F8.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/2D/2DB92278-36AB-48C6-B4CD-A2613B4125F8/2DB92278-36AB-48C6-B4CD-A2613B4125F8.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1038/msb.2008.53}}
}

@article{Yeh:2007in,
author = {Yeh, Pamela and Kishony, Roy},
title = {{Networks from drug-drug surfaces}},
journal = {Molecular Systems Biology},
year = {2007},
volume = {3},
month = feb,
keywords = {recommended by Andreas},
doi = {10.1038/msb4100133},
read = {Yes},
rating = {0},
date-added = {2013-11-11T23:47:52GMT},
date-modified = {2014-12-08T14:14:21GMT},
url = {http://www.nature.com/doifinder/10.1038/msb4100133},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/3B/3B478F77-ECF7-4267-8674-296CC2300D5B/3B478F77-ECF7-4267-8674-296CC2300D5B.pdf},
file = {{3B478F77-ECF7-4267-8674-296CC2300D5B.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/3B/3B478F77-ECF7-4267-8674-296CC2300D5B/3B478F77-ECF7-4267-8674-296CC2300D5B.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1038/msb4100133}}
}

@article{Yin:2014bv,
author = {Yin, Ning and Ma, Wenzhe and Pei, Jianfeng and Ouyang, Qi and Tang, Chao and Lai, Luhua},
title = {{Synergistic and antagonistic drug combinations depend on network topology.}},
journal = {PLoS ONE},
year = {2014},
volume = {9},
number = {4},
pages = {e93960},
publisher = {Public Library of Science},
affiliation = {Center for Quantitative Biology, Peking University, Beijing, China.},
doi = {10.1371/journal.pone.0093960},
pmid = {24713621},
pmcid = {PMC3979733},
language = {English},
read = {Yes},
rating = {0},
date-added = {2014-08-05T16:13:53GMT},
date-modified = {2014-11-25T17:36:16GMT},
abstract = {Drug combinations may exhibit synergistic or antagonistic effects. Rational design of synergistic drug combinations remains a challenge despite active experimental and computational efforts. Because drugs manifest their action via their targets, the effects of drug combinations should depend on the interaction of their targets in a network manner. We therefore modeled the effects of drug combinations along with their targets interacting in a network, trying to elucidate the relationships between the network topology involving drug targets and drug combination effects. We used three-node enzymatic networks with various topologies and parameters to study two-drug combinations. These networks can be simplifications of more complex networks involving drug targets, or closely connected target networks themselves. We found that the effects of most of the combinations were not sensitive to parameter variation, indicating that drug combinational effects largely depend on network topology. We then identified and analyzed consistent synergistic or antagonistic drug combination motifs. Synergistic motifs encompass a diverse range of patterns, including both serial and parallel combinations, while antagonistic combinations are relatively less common and homogenous, mostly composed of a positive feedback loop and a downstream link. Overall our study indicated that designing novel synergistic drug combinations based on network topology could be promising, and the motifs we identified could be a useful catalog for rational drug combination design in enzymatic systems.},
url = {http://dx.plos.org/10.1371/journal.pone.0093960},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/81/81C1B904-1EE5-4930-BB85-6F281CF12A83.pdf},
file = {{81C1B904-1EE5-4930-BB85-6F281CF12A83.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/81/81C1B904-1EE5-4930-BB85-6F281CF12A83.pdf:application/pdf;81C1B904-1EE5-4930-BB85-6F281CF12A83.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/81/81C1B904-1EE5-4930-BB85-6F281CF12A83.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1371/journal.pone.0093960}}
}

@article{Pedregosa2011,
author = {Pedregosa, F and Varoquaux, G and Gramfort, A and Michel, V and Thirion, B and Grisel, O and Blondel, M and Prettenhofer, P and Weiss, R and Dubourg, V and Vanderplas, J and Passos, A and Cournapeau, D and Brucher, M and Perrot, M and Duchesnay, E},
title = {{Scikit-learn: Machine Learning in Python}},
journal = {Journal of Machine Learning Research},
year = {2011},
volume = {12},
pages = {2825--2830},
month = oct,
rating = {0},
date-added = {2014-06-10T19:42:42GMT},
date-modified = {2015-03-26T12:22:03GMT},
url = {http://jmlr.org/papers/v12/pedregosa11a.html},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/16/16C8E3BB-393C-418F-9E37-F511FE50DC5E.pdf},
file = {{16C8E3BB-393C-418F-9E37-F511FE50DC5E.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/16/16C8E3BB-393C-418F-9E37-F511FE50DC5E.pdf:application/pdf;16C8E3BB-393C-418F-9E37-F511FE50DC5E.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/16/16C8E3BB-393C-418F-9E37-F511FE50DC5E.pdf:application/pdf}},
uri = {\url{papers3://publication/uuid/0DEAC544-CDE0-4F08-9DC5-DBB65577FE87}}
}

@article{Christmas:2005tq,
author = {Christmas, Rowan and Avila-Campillo, Iliana and Bolouri, Hamid and Schwikowski, Benno and Anderson, Mark and Kelley, Ryan and Landys, Nerius and Workman, Chris and Ideker, Trey and Cerami, Ethan and Sheridan, Rob and Bader, Gary D and Sander, Chris},
title = {{Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks}},
journal = {AACR Education Book},
year = {2005},
volume = {2005},
number = {1},
pages = {12},
month = apr,
read = {Yes},
rating = {0},
date-added = {2015-03-09T02:00:05GMT},
date-modified = {2015-03-26T12:13:37GMT},
url = {http://educationbook.aacrjournals.org/cgi/content/full/2005/1/12},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/A9/A971A415-DF78-4A0D-908C-6F61D41AEE5F.pdf},
file = {{A971A415-DF78-4A0D-908C-6F61D41AEE5F.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/A9/A971A415-DF78-4A0D-908C-6F61D41AEE5F.pdf:application/pdf;A971A415-DF78-4A0D-908C-6F61D41AEE5F.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/A9/A971A415-DF78-4A0D-908C-6F61D41AEE5F.pdf:application/pdf}},
uri = {\url{papers3://publication/uuid/1A71CDCB-883E-42B2-956C-B78EA36B716B}}
}

@article{Bulusu2015:td,
author = {Bulusu, Krishna C and Guha, Rajarshi and Mason, Daniel J and Lewis, Richard P. I. and Muratov, Eugene N and Motamedi, Yasaman Kalantar and Cokol, Murat and Bender, Andreas},
title = {{Modelling of Compound Combination Effects and Applications to Efficacy and Toxicity: State-of-the-Art, Challenges and Perspectives}},
journal = {Drug Discovery Today},
rating = {0},
date-added = {2015-03-26T12:17:41GMT},
date-modified = {2015-03-26T12:23:47GMT},
abstract = {The development of treatments involving combinations of drugs is a logical approach towards combating complex or multifactorial disorders. However, the large number of compound combinations that can be generated, from even small compound collections, means that exhaustive experimental testing infeasible. The ability to predict the behaviour of compound combinations in biological systems, whittling down the number of combinations to be tested, is therefore key. Here we review the current state-of-the-art in the field of compound combination modelling, with the aim to support the development of approaches that, as we hope, will finally lead to an integration of chemical with systems-level biological information for predicting the effect of chemical mixtures. },
uri = {\url{papers3://publication/uuid/E65CB3A7-AE7B-4FA5-A935-3EC19747AF88}}
}

@article{TorneroVelez:2011cs,
author = {Tornero-Velez, Rogelio and Egeghy, Peter P and Cohen Hubal, Elaine A},
title = {{Biogeographical Analysis of Chemical Co-Occurrence Data to Identify Priorities for Mixtures Research}},
journal = {Risk Analysis},
year = {2011},
volume = {32},
number = {2},
pages = {224--236},
month = jul,
keywords = {recommended by Andreas},
doi = {10.1111/j.1539-6924.2011.01658.x},
language = {English},
rating = {0},
date-added = {2013-11-11T23:36:17GMT},
date-modified = {2014-11-25T12:51:04GMT},
url = {http://doi.wiley.com/10.1111/j.1539-6924.2011.01658.x},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/DE/DEE53D2B-D27B-423D-9BC2-4EA38ECB0394/DEE53D2B-D27B-423D-9BC2-4EA38ECB0394.pdf},
file = {{DEE53D2B-D27B-423D-9BC2-4EA38ECB0394.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/DE/DEE53D2B-D27B-423D-9BC2-4EA38ECB0394/DEE53D2B-D27B-423D-9BC2-4EA38ECB0394.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1111/j.1539-6924.2011.01658.x}}
}

@article{Tan:2012gf,
author = {Tan, Xu and Hu, Long and Luquette, Lovelace J and Gao, Geng and Liu, Yifang and Qu, Hongjing and Xi, Ruibin and Lu, Zhi John and Park, Peter J and Elledge, Stephen J},
title = {{Systematic identification of synergistic drug pairs targeting HIV.}},
journal = {Nature Biotechnology},
year = {2012},
volume = {30},
number = {11},
pages = {1125--1130},
month = nov,
affiliation = {Howard Hughes Medical Institute, Department of Genetics, Harvard Medical School, Division of Genetics, Brigham and Women's Hospital, Boston, Massachusetts, USA.},
doi = {10.1038/nbt.2391},
pmid = {23064238},
pmcid = {PMC3494743},
language = {English},
read = {Yes},
rating = {0},
date-added = {2014-11-24T19:06:00GMT},
date-modified = {2015-03-08T17:39:14GMT},
abstract = {The systematic identification of effective drug combinations has been hindered by the unavailability of methods that can explore the large combinatorial search space of drug interactions. Here we present multiplex screening for interacting compounds (MuSIC), which expedites the comprehensive assessment of pairwise compound interactions. We examined 500,000 drug pairs from 1,000 US Food and Drug Administration (FDA)-approved or clinically tested drugs and identified drugs that synergize to inhibit HIV replication. Our analysis reveals an enrichment of anti-inflammatory drugs in drug combinations that synergize against HIV. As inflammation accompanies HIV infection, these findings indicate that inhibiting inflammation could curb HIV propagation. Multiple drug pairs identified in this study, including various glucocorticoids and nitazoxanide (NTZ), synergize by targeting different steps in the HIV life cycle. MuSIC can be applied to a wide variety of disease-relevant screens to facilitate efficient identification of compound combinations.},
url = {http://www.nature.com/doifinder/10.1038/nbt.2391},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/AD/ADA7B735-A8AE-4756-9C87-E1767ADAF7AD.pdf},
file = {{ADA7B735-A8AE-4756-9C87-E1767ADAF7AD.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/AD/ADA7B735-A8AE-4756-9C87-E1767ADAF7AD.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1038/nbt.2391}}
}

@article{Yap:2011gf,
author = {Yap, C W},
title = {{PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints}},
journal = {Journal of computational chemistry},
year = {2011},
volume = {32},
number = {7},
pages = {1466--1474},
publisher = {Wiley Subscription Services, Inc., A Wiley Company},
affiliation = {Department of Pharmacy, Pharmaceutical Data Exploration Laboratory, National University of Singapore, Singapore. phayapc@nus.edu.sg},
doi = {10.1002/jcc.21707},
pmid = {21425294},
language = {English},
read = {Yes},
rating = {0},
date-added = {2014-01-20T15:35:06GMT},
date-modified = {2015-03-26T12:22:03GMT},
abstract = {INTRODUCTION:PaDEL-Descriptor is a software for calculating molecular descriptors and fingerprints. The software currently calculates 797 descriptors (663 1D, 2D descriptors, and 134 3D descriptors) and 10 types of fingerprints. These descriptors and fingerprints are calculated mainly using The Chemistry Development Kit. Some additional descriptors and fingerprints were added, which include atom type electrotopological state descriptors, McGowan volume, molecular linear free energy relation descriptors, ring counts, count of chemical substructures identified by Laggner, and binary fingerprints and count of chemical substructures identified by Klekota and Roth.

METHODS:PaDEL-Descriptor was developed using the Java language and consists of a library component and an interface component. The library component allows it to be easily integrated into quantitative structure activity relationship software to provide the descriptor calculation feature while the interface component allows it to be used as a standalone software. The software uses a Master/Worker pattern to take advantage of the multiple CPU cores that are present in most modern computers to speed up calculations of molecular descriptors.

RESULTS:The software has several advantages over existing standalone molecular descriptor calculation software. It is free and open source, has both graphical user interface and command line interfaces, can work on all major platforms (Windows, Linux, MacOS), supports more than 90 different molecular file formats, and is multithreaded.

CONCLUSION:PaDEL-Descriptor is a useful addition to the currently available molecular descriptor calculation software. The software can be downloaded at http://padel.nus.edu.sg/software/padeldescriptor.},
url = {http://doi.wiley.com/10.1002/jcc.21707},
local-url = {file://localhost/Users/RichLewis/Dropbox/Library.papers3/Files/BF/BF2D9549-D9E8-4C9F-842B-F7D7A38814BA.pdf},
file = {{BF2D9549-D9E8-4C9F-842B-F7D7A38814BA.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/BF/BF2D9549-D9E8-4C9F-842B-F7D7A38814BA.pdf:application/pdf;BF2D9549-D9E8-4C9F-842B-F7D7A38814BA.pdf:/Users/RichLewis/Dropbox/Library.papers3/Files/BF/BF2D9549-D9E8-4C9F-842B-F7D7A38814BA.pdf:application/pdf}},
uri = {\url{papers3://publication/doi/10.1002/jcc.21707}}
}

